Exact Mass: 295.1644

Exact Mass Matches: 295.1644

Found 122 metabolites which its exact mass value is equals to given mass value 295.1644, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Tertatolol

1-(tert-butylamino)-3-(3,4-dihydro-2H-1-benzothiopyran-8-yloxy)propan-2-ol

C16H25NO2S (295.1606)


Tertatolol (Artex, Artexal, Prenalex) is a medication in the class of beta blockers, used in the treatment of high blood pressure. It was discovered by the French pharmaceutical company Servier and is marketed in Europe. C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AA - Beta blocking agents, non-selective C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents

   

(E)-Herclavine

(2E)-N-[2-(4-methoxyphenyl)ethyl]-N-methyl-3-phenylprop-2-enamide

C19H21NO2 (295.1572)


(E)-Herclavine is found in herbs and spices. (E)-Herclavine is an alkaloid from the bark of Zanthoxylum clava-herculis (Hercules club

   

Doxepin N-oxide

N,N-dimethyl-3-[(2E)-9-oxatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene]propanamine oxide

C19H21NO2 (295.1572)


Doxepin N-oxide (CAS: 22684-91-9) is a metabolite of doxepin. Doxepin is a psychotropic agent with tricyclic antidepressant and anxiolytic properties, known under many brand-names such as Aponal, Adapine, Doxal, Deptran, Sinquan, and Sinequan. As doxepin hydrochloride, it is the active ingredient in cream-based preparations (Zonalon and Xepin) for the treatment of dermatological itch (Wikipedia).

   

(E)-2-hydroxydoxepin

(2Z)-2-[3-(dimethylamino)propylidene]-9-oxatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3,5,7,12,14-hexaen-5-ol

C19H21NO2 (295.1572)


(E)-2-hydroxydoxepin is a metabolite of doxepin. Doxepin is a psychotropic agent with tricyclic antidepressant and anxiolytic properties, known under many brand-names such as Aponal, the original preparation by Boehringer-Mannheim, now part of the Roche group; Adapine, Doxal, Deptran, Sinquan and Sinequan. As doxepin hydrochloride, it is the active ingredient in cream-based preparations (Zonalon and Xepin) for the treatment of dermatological itch. (Wikipedia)

   

1,2-Dimethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline

15,16-dimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaene

C19H21NO2 (295.1572)


   

Cyclohexyl biphenyl-3-ylcarbamate

cyclohexyl N-{[1,1-biphenyl]-3-yl}carbamate

C19H21NO2 (295.1572)


URB602 is a selective monoacylglycerol lipase (MGL) inhibitor, which inhibits rat brain MGL with IC50 of 28±4 μM through a noncompetitive mechanism.

   

Dibenzepin

9-[2-(dimethylamino)ethyl]-2-methyl-2,9-diazatricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3,5,7,11,13-hexaen-10-one

C18H21N3O (295.1685)


N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AA - Non-selective monoamine reuptake inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent > C94727 - Tricyclic Antidepressant D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents

   

2-[[2-(4-Hydroxyphenyl)ethylamino]methyl]-3,4-dihydro-2H-naphthalen-1-one

2-({[2-(4-hydroxyphenyl)ethyl]amino}methyl)-1,2,3,4-tetrahydronaphthalen-1-one

C19H21NO2 (295.1572)


D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists

   

levo-tetrahydropalmatine

9,10-Dimethoxy-5,6,13,13a-tetrahydro-8H-dibenzo[a,g]quinolizine

C19H21NO2 (295.1572)


   

N-n-Propylnorapomorphine

10-propyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,13,15-hexaene-3,4-diol

C19H21NO2 (295.1572)


D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists

   

Pitolisant

1-{3-[3-(4-chlorophenyl)propoxy]propyl}piperidine

C17H26ClNO (295.1703)


C78272 - Agent Affecting Nervous System N - Nervous system Pitolisant is a potent and selective nonimidazole inverse agonist at the recombinant human histamine H3 receptor (Ki=0.16 nM).

   

Nuciferine

4H-DIBENZO(DE,G)QUINOLINE, 5,6,6A,7-TETRAHYDRO-1,2-DIMETHOXY-6-METHYL-, (6AR)-

C19H21NO2 (295.1572)


CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2317 Nuciferine is a natural product found in Cissampelos pareira, Paliurus hemsleyanus, and other organisms with data available. Nuciferine is an antagonist at 5-HT2A (IC50=478 nM), 5-HT2C (IC50=131 nM), and 5-HT2B (IC50=1 μM), an inverse agonist at 5-HT7 (IC50=150 nM), a partial agonist at D2 (EC50=64 nM), D5 (EC50=2.6 μM) and 5-HT6 (EC50=700 nM), an agonist at 5-HT1A (EC50=3.2 μM) and D4 (EC50=2 μM) receptor. Nuciferine is an antagonist at 5-HT2A (IC50=478 nM), 5-HT2C (IC50=131 nM), and 5-HT2B (IC50=1 μM), an inverse agonist at 5-HT7 (IC50=150 nM), a partial agonist at D2 (EC50=64 nM), D5 (EC50=2.6 μM) and 5-HT6 (EC50=700 nM), an agonist at 5-HT1A (EC50=3.2 μM) and D4 (EC50=2 μM) receptor. Nuciferine is an antagonist at 5-HT2A (IC50=478 nM), 5-HT2C (IC50=131 nM), and 5-HT2B (IC50=1 μM), an inverse agonist at 5-HT7 (IC50=150 nM), a partial agonist at D2 (EC50=64 nM), D5 (EC50=2.6 μM) and 5-HT6 (EC50=700 nM), an agonist at 5-HT1A (EC50=3.2 μM) and D4 (EC50=2 μM) receptor.

   

(+/-)-NUCIFERINE

(+/-)-NUCIFERINE

C19H21NO2 (295.1572)


   

Axinisothiocyanate C

Axinisothiocyanate C

C16H25NO2S (295.1606)


   
   

Axinisothiocyanate N

Axinisothiocyanate N

C16H25NO2S (295.1606)


   

Murrayafoline B

Murrayafoline B

C19H21NO2 (295.1572)


   
   
   

Axinisothiocyanate F

Axinisothiocyanate F

C16H25NO2S (295.1606)


   

Carbazoquinocin A

(S)-2-Methyl-1-(3-methylpentyl)-3H-carbazole-3,4(9H)-dione

C19H21NO2 (295.1572)


   
   

Isomurrayafoline B

Isomurrayafoline B

C19H21NO2 (295.1572)


   

Axinisothiocyanate G

Axinisothiocyanate G

C16H25NO2S (295.1606)


   

Dibenzepin

Dibenzepin

C18H21N3O (295.1685)


N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AA - Non-selective monoamine reuptake inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent > C94727 - Tricyclic Antidepressant D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents

   

N-Propylnorapomorphine

N-Propylnorapomorphine

C19H21NO2 (295.1572)


D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists

   

URB602

[1,1-biphenyl]-3-yl-carbamic acid, cyclohexyl ester

C19H21NO2 (295.1572)


URB602 is a selective monoacylglycerol lipase (MGL) inhibitor, which inhibits rat brain MGL with IC50 of 28±4 μM through a noncompetitive mechanism.

   

Estrone cyanate

Estrone cyanate

C19H21NO2 (295.1572)


   

SCHEMBL18025633

SCHEMBL18025633

C18H21N3O (295.1685)


   

Noratherosperminine

Noratherosperminine

C19H21NO2 (295.1572)


   

N-methyllaurotetanine

N-methyllaurotetanine

C19H21NO2 (295.1572)


   
   
   

1-(2-Dimethylamino-aethyl)-3-methoxy-phenanthren-4-ol|1-<2-Dimethylamino-aethyl>-3-methoxy-phenanthren-4-ol

1-(2-Dimethylamino-aethyl)-3-methoxy-phenanthren-4-ol|1-<2-Dimethylamino-aethyl>-3-methoxy-phenanthren-4-ol

C19H21NO2 (295.1572)


   

hydroxydoxepin M1

hydroxydoxepin M1

C19H21NO2 (295.1572)


   

hydroxydoxepin M2

hydroxydoxepin M2

C19H21NO2 (295.1572)


   

hydroxydoxepin M3

hydroxydoxepin M3

C19H21NO2 (295.1572)


   

hydroxydoxepin M4

hydroxydoxepin M4

C19H21NO2 (295.1572)


   

(E)-Herclavine

(2E)-N-[2-(4-methoxyphenyl)ethyl]-N-methyl-3-phenylprop-2-enamide

C19H21NO2 (295.1572)


   

TERTATOLOL

tert-butyl[3-(3,4-dihydro-2H-1-benzothiopyran-8-yloxy)-2-hydroxypropyl]amine

C16H25NO2S (295.1606)


C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AA - Beta blocking agents, non-selective C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents

   

2-Methyl-2-propanyl 2-{[4-(2-aminoethyl)phenyl]sulfanyl}-2-methyl propanoate

2-Methyl-2-propanyl 2-{[4-(2-aminoethyl)phenyl]sulfanyl}-2-methyl propanoate

C16H25NO2S (295.1606)


   

2-BENZOXAZOL-2-YL-1-(4-TERTBUTYLPHENYL)ETHANOL

2-BENZOXAZOL-2-YL-1-(4-TERTBUTYLPHENYL)ETHANOL

C19H21NO2 (295.1572)


   

N-phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline

N-phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline

C18H22BNO2 (295.1744)


   

2,2-DIPHENYL-1-ETHYLBORONIC ACID DIETHANOLAMINE ESTER

2,2-DIPHENYL-1-ETHYLBORONIC ACID DIETHANOLAMINE ESTER

C18H22BNO2 (295.1744)


   
   
   

4-(2-Fluorophenoxy)-1-piperidinecarboxylic acid tert-butyl ester

4-(2-Fluorophenoxy)-1-piperidinecarboxylic acid tert-butyl ester

C16H22FNO3 (295.1584)


   
   

(R)-(+)-5,5-DIPHENYL-4-ISOBUTYL-2-OXAZOLIDINONE

(R)-(+)-5,5-DIPHENYL-4-ISOBUTYL-2-OXAZOLIDINONE

C19H21NO2 (295.1572)


   

Methyl 1-benzyl-3-phenyl-3-pyrrolidinecarboxylate

Methyl 1-benzyl-3-phenyl-3-pyrrolidinecarboxylate

C19H21NO2 (295.1572)


   

tert-Butyl 4-(4-amino-2-fluorophenyl)piperazine-1-carboxylate

tert-Butyl 4-(4-amino-2-fluorophenyl)piperazine-1-carboxylate

C15H22FN3O2 (295.1696)


   

4-BOC-2-(4-FLUOROPHENYL)-2-METHYLMORPHOLINE

4-BOC-2-(4-FLUOROPHENYL)-2-METHYLMORPHOLINE

C16H22FNO3 (295.1584)


   

methyl 1-benzyl-4-phenylpyrrolidine-3-carboxylate

methyl 1-benzyl-4-phenylpyrrolidine-3-carboxylate

C19H21NO2 (295.1572)


   

Benzyl N-Benzylpyrrolidine-3-carboxylate

Benzyl N-Benzylpyrrolidine-3-carboxylate

C19H21NO2 (295.1572)


   

N-Cyclohexylcarbamic acid [1,1-biphenyl]-3-yl ester

N-Cyclohexylcarbamic acid [1,1-biphenyl]-3-yl ester

C19H21NO2 (295.1572)


   

Eperisone hydrochloride

Eperisone hydrochloride

C17H26ClNO (295.1703)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002491 - Central Nervous System Agents > D000927 - Anticonvulsants D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators

   

1-[4-[4-(pyridin-2-ylmethyl)piperazin-1-yl]phenyl]ethanone

1-[4-[4-(pyridin-2-ylmethyl)piperazin-1-yl]phenyl]ethanone

C18H21N3O (295.1685)


   

Ethyl 1-(diphenylmethyl)-3-azetidinecarboxylate

Ethyl 1-(diphenylmethyl)-3-azetidinecarboxylate

C19H21NO2 (295.1572)


   

1-[4-[(4-butoxyphenyl)methylideneamino]phenyl]ethanone

1-[4-[(4-butoxyphenyl)methylideneamino]phenyl]ethanone

C19H21NO2 (295.1572)


   

(S)-(-)-5,5-DIPHENYL-4-ISOBUTYL-2-OXAZOLIDINONE

(S)-(-)-5,5-DIPHENYL-4-ISOBUTYL-2-OXAZOLIDINONE

C19H21NO2 (295.1572)


   

1,3-Dibenzyl-3-pyrrolidinecarboxylic acid

1,3-Dibenzyl-3-pyrrolidinecarboxylic acid

C19H21NO2 (295.1572)


   

(S)-(-)-4-(2-CHLOROPHENYL)-2-HYDROXY-5,5-DIMETHYL-1,3,2-DIOXAPHOSPHORINANE2-OXIDE

(S)-(-)-4-(2-CHLOROPHENYL)-2-HYDROXY-5,5-DIMETHYL-1,3,2-DIOXAPHOSPHORINANE2-OXIDE

C19H21NO2 (295.1572)


   

4-Hydroxy tolbutamide

hydroxy tolbutamide-d9

C12H9D9N2O4S (295.1552)


4-Hydroxy tolbutamide is a hydroxylation byproduct of tolbutamide. Tolbutamide is a first generation potassium channel blocker. It is a sulfonylurea oral hypoglycemic drug sold under the brand name Orinase. This drug may be used in the management of type II diabetes if diet alone is not effective. Tolbutamide stimulates the secretion of insulin by the pancreas. [HMDB]

   

3-morpholin-4-yl-1,2-diphenylpropan-1-one

3-morpholin-4-yl-1,2-diphenylpropan-1-one

C19H21NO2 (295.1572)


   

1-benzyl-4-phenylpiperidine-4-carboxylic acid

1-benzyl-4-phenylpiperidine-4-carboxylic acid

C19H21NO2 (295.1572)


   

beta-1-Cyclohexen-1-yl-4-methoxy-N,N-dimethylbenzeneethanamine hydrochloride

beta-1-Cyclohexen-1-yl-4-methoxy-N,N-dimethylbenzeneethanamine hydrochloride

C17H26ClNO (295.1703)


   
   

Oxitriptyline

Oxitriptyline

C19H21NO2 (295.1572)


   

(1-(1-(TERT-BUTOXYCARBONYL)PIPERIDIN-4-YL)-1H-PYRAZOL-4-YL)BORONIC ACID

(1-(1-(TERT-BUTOXYCARBONYL)PIPERIDIN-4-YL)-1H-PYRAZOL-4-YL)BORONIC ACID

C13H22BN3O4 (295.1703)


   

tert-Butyl 2-((diphenylmethylene)amino)acetate

tert-Butyl 2-((diphenylmethylene)amino)acetate

C19H21NO2 (295.1572)


   

Lysergic acid ethylamide

9,10-Didehydro-N-ethyl-6-methylergoline-8β-carboxamide

C18H21N3O (295.1685)


   

(4-(Benzyloxy)phenyl)(piperidin-4-yl)Methanone

(4-(Benzyloxy)phenyl)(piperidin-4-yl)Methanone

C19H21NO2 (295.1572)


   

2O-Me-rA(bz) CPG500

2O-Me-rA(bz) CPG500

C13H21N5O3 (295.1644)


   

D(+)-VESAMICOL HYDROCHLORIDE

D(+)-VESAMICOL HYDROCHLORIDE

C17H26ClNO (295.1703)


   

ethyl 1-benzhydrylazetidine-2-carboxylate

ethyl 1-benzhydrylazetidine-2-carboxylate

C19H21NO2 (295.1572)


   

P,P-di(aziridin-1-yl)-N-(2-(diethylamino)pyridin-4-yl)phosphinic amide

P,P-di(aziridin-1-yl)-N-(2-(diethylamino)pyridin-4-yl)phosphinic amide

C13H22N5OP (295.1562)


   

(1,2,4)Triazolo(1,5-a)pyrazine

(1,2,4)Triazolo(1,5-a)pyrazine

C18H21N3O (295.1685)


   

H-Glu(OtBu)-OtBu.HCl

H-Glu(OtBu)-OtBu.HCl

C13H26ClNO4 (295.155)


   

Beloxepin

Beloxepin

C19H21NO2 (295.1572)


C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

   

3-Allyl-2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine

3-Allyl-2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine

C19H21NO2 (295.1572)


D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists

   

2-{[(1-butyl-1H-benzimidazol-2-yl)amino]methyl}phenol

2-{[(1-butyl-1H-benzimidazol-2-yl)amino]methyl}phenol

C18H21N3O (295.1685)


   

(6aS)-6-propyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol

(6aS)-6-propyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol

C19H21NO2 (295.1572)


   

6-Phenyl-5-(1-piperidinyl)-2-prop-2-enyl-3-pyridazinone

6-Phenyl-5-(1-piperidinyl)-2-prop-2-enyl-3-pyridazinone

C18H21N3O (295.1685)


   

3,4-dihydro-2H-quinolin-1-yl-(4-propoxyphenyl)methanone

3,4-dihydro-2H-quinolin-1-yl-(4-propoxyphenyl)methanone

C19H21NO2 (295.1572)


   

Pitolisant

Pitolisant

C17H26ClNO (295.1703)


C78272 - Agent Affecting Nervous System N - Nervous system Pitolisant is a potent and selective nonimidazole inverse agonist at the recombinant human histamine H3 receptor (Ki=0.16 nM).

   

Nuciferin

4H-Dibenzo(de,g)quinoline, 5,6,6a,7-tetrahydro-1,2-dimethoxy-6-methyl-, (R)- (9CI)

C19H21NO2 (295.1572)


Nuciferine is an antagonist at 5-HT2A (IC50=478 nM), 5-HT2C (IC50=131 nM), and 5-HT2B (IC50=1 μM), an inverse agonist at 5-HT7 (IC50=150 nM), a partial agonist at D2 (EC50=64 nM), D5 (EC50=2.6 μM) and 5-HT6 (EC50=700 nM), an agonist at 5-HT1A (EC50=3.2 μM) and D4 (EC50=2 μM) receptor. Nuciferine is an antagonist at 5-HT2A (IC50=478 nM), 5-HT2C (IC50=131 nM), and 5-HT2B (IC50=1 μM), an inverse agonist at 5-HT7 (IC50=150 nM), a partial agonist at D2 (EC50=64 nM), D5 (EC50=2.6 μM) and 5-HT6 (EC50=700 nM), an agonist at 5-HT1A (EC50=3.2 μM) and D4 (EC50=2 μM) receptor. Nuciferine is an antagonist at 5-HT2A (IC50=478 nM), 5-HT2C (IC50=131 nM), and 5-HT2B (IC50=1 μM), an inverse agonist at 5-HT7 (IC50=150 nM), a partial agonist at D2 (EC50=64 nM), D5 (EC50=2.6 μM) and 5-HT6 (EC50=700 nM), an agonist at 5-HT1A (EC50=3.2 μM) and D4 (EC50=2 μM) receptor.

   

5,8,11,14-Eicosatetraynoate

5,8,11,14-Eicosatetraynoate

C20H23O2- (295.1698)


   

3-Phenyl-1-(4-pyridin-2-ylpiperazin-1-yl)propan-1-one

3-Phenyl-1-(4-pyridin-2-ylpiperazin-1-yl)propan-1-one

C18H21N3O (295.1685)


   

9-methyl-3-[(2-methyl-1-imidazolyl)methyl]-2,3,4a,9a-tetrahydro-1H-carbazol-4-one

9-methyl-3-[(2-methyl-1-imidazolyl)methyl]-2,3,4a,9a-tetrahydro-1H-carbazol-4-one

C18H21N3O (295.1685)


   

N-[3-(dimethylamino)propyl]-9H-carbazole-3-carboxamide

N-[3-(dimethylamino)propyl]-9H-carbazole-3-carboxamide

C18H21N3O (295.1685)


   

N-(cyclopentylideneamino)-4-(2,5-dimethyl-1-pyrrolyl)benzamide

N-(cyclopentylideneamino)-4-(2,5-dimethyl-1-pyrrolyl)benzamide

C18H21N3O (295.1685)


   

N-[(3-methoxyphenyl)methyl]-1-propyl-5-benzimidazolamine

N-[(3-methoxyphenyl)methyl]-1-propyl-5-benzimidazolamine

C18H21N3O (295.1685)


   

3-[3-(4-isopropylphenyl)acryloyl]-4,6-dimethyl-2(1H)-pyridinone

3-[3-(4-isopropylphenyl)acryloyl]-4,6-dimethyl-2(1H)-pyridinone

C19H21NO2 (295.1572)


   

(E)-N-cycloheptyl-3-quinoxalin-2-ylprop-2-enamide

(E)-N-cycloheptyl-3-quinoxalin-2-ylprop-2-enamide

C18H21N3O (295.1685)


   

2-Ethyl-4-(3-methyl-1-piperidinyl)benzofuro[3,2-d]pyrimidine

2-Ethyl-4-(3-methyl-1-piperidinyl)benzofuro[3,2-d]pyrimidine

C18H21N3O (295.1685)


   

2-[[2-(4-Hydroxyphenyl)ethylamino]methyl]-3,4-dihydro-2H-naphthalen-1-one

2-[[2-(4-Hydroxyphenyl)ethylamino]methyl]-3,4-dihydro-2H-naphthalen-1-one

C19H21NO2 (295.1572)


D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists

   

(E)-2-hydroxydoxepin

(E)-2-hydroxydoxepin

C19H21NO2 (295.1572)


   

Doxepin N-oxide

Doxepin N-oxide

C19H21NO2 (295.1572)


   

(8R)-7-propyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-13,14-diol

(8R)-7-propyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-13,14-diol

C19H21NO2 (295.1572)


   

2,2-dimethyl-7-(2-methylbut-3-en-2-yl)-8h-chromeno[7,6-b]pyrrole-6-carbaldehyde

2,2-dimethyl-7-(2-methylbut-3-en-2-yl)-8h-chromeno[7,6-b]pyrrole-6-carbaldehyde

C19H21NO2 (295.1572)


   

2-methyl-1-[(3s)-3-methylpentyl]-9h-carbazole-3,4-dione

2-methyl-1-[(3s)-3-methylpentyl]-9h-carbazole-3,4-dione

C19H21NO2 (295.1572)


   

axinisothiocyanate a

axinisothiocyanate a

C16H25NO2S (295.1606)


   

axinisothiocyanate b

axinisothiocyanate b

C16H25NO2S (295.1606)


   

7-methoxy-3-methyl-8-(3-methylbut-2-en-1-yl)-9h-carbazol-1-ol

7-methoxy-3-methyl-8-(3-methylbut-2-en-1-yl)-9h-carbazol-1-ol

C19H21NO2 (295.1572)


   

8-isothiocyanato-4a,8-dimethyl-2-(prop-1-en-2-yl)-hexahydro-1h-naphthalene-2-peroxol

8-isothiocyanato-4a,8-dimethyl-2-(prop-1-en-2-yl)-hexahydro-1h-naphthalene-2-peroxol

C16H25NO2S (295.1606)


   

(9s)-5-isopropyl-9-methyl-15-azatetracyclo[7.6.1.0²,⁶.0¹³,¹⁶]hexadeca-1,4,6,13(16)-tetraene-3,14-dione

(9s)-5-isopropyl-9-methyl-15-azatetracyclo[7.6.1.0²,⁶.0¹³,¹⁶]hexadeca-1,4,6,13(16)-tetraene-3,14-dione

C19H21NO2 (295.1572)


   

n-[2-(4-methoxyphenyl)ethyl]-n-methyl-3-phenylprop-2-enamide

n-[2-(4-methoxyphenyl)ethyl]-n-methyl-3-phenylprop-2-enamide

C19H21NO2 (295.1572)


   

8-isopropyl-5-isothiocyanato-2,5-dimethyl-1,3,4,4a,6,7-hexahydronaphthalene-1,2-diol

8-isopropyl-5-isothiocyanato-2,5-dimethyl-1,3,4,4a,6,7-hexahydronaphthalene-1,2-diol

C16H25NO2S (295.1606)


   

axinisothiocyanate e

axinisothiocyanate e

C16H25NO2S (295.1606)


   

(2r,4as,5r,8s)-8-isopropyl-5-isothiocyanato-2,5-dimethyl-4,6,7,8-tetrahydro-3h-naphthalene-2,4a-diol

(2r,4as,5r,8s)-8-isopropyl-5-isothiocyanato-2,5-dimethyl-4,6,7,8-tetrahydro-3h-naphthalene-2,4a-diol

C16H25NO2S (295.1606)


   

[2-(3,4-dimethoxyphenanthren-1-yl)ethyl](methyl)amine

[2-(3,4-dimethoxyphenanthren-1-yl)ethyl](methyl)amine

C19H21NO2 (295.1572)


   

(9s)-15,16-dimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaene

(9s)-15,16-dimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaene

C19H21NO2 (295.1572)


   

axinisothiocyanate d

axinisothiocyanate d

C16H25NO2S (295.1606)


   

n-(2-{4-[(2-methylprop-1-en-1-yl)oxy]phenyl}ethyl)benzenecarboximidic acid

n-(2-{4-[(2-methylprop-1-en-1-yl)oxy]phenyl}ethyl)benzenecarboximidic acid

C19H21NO2 (295.1572)


   

2,2-dimethyl-7-(2-methylbut-3-en-2-yl)chromeno[7,6-b]pyridin-8-ol

2,2-dimethyl-7-(2-methylbut-3-en-2-yl)chromeno[7,6-b]pyridin-8-ol

C19H21NO2 (295.1572)


   

2-[2-(2h-1,3-benzodioxol-5-yl)ethyl]-1-methyl-3,4-dihydro-2h-quinoline

2-[2-(2h-1,3-benzodioxol-5-yl)ethyl]-1-methyl-3,4-dihydro-2h-quinoline

C19H21NO2 (295.1572)


   

1-[2-(dimethylamino)ethyl]-4-methoxyphenanthren-3-ol

1-[2-(dimethylamino)ethyl]-4-methoxyphenanthren-3-ol

C19H21NO2 (295.1572)


   

(2s)-2-[2-(2h-1,3-benzodioxol-5-yl)ethyl]-1-methyl-3,4-dihydro-2h-quinoline

(2s)-2-[2-(2h-1,3-benzodioxol-5-yl)ethyl]-1-methyl-3,4-dihydro-2h-quinoline

C19H21NO2 (295.1572)


   

6-methoxy-3-methyl-5-(3-methylbut-2-en-1-yl)-9h-carbazol-2-ol

6-methoxy-3-methyl-5-(3-methylbut-2-en-1-yl)-9h-carbazol-2-ol

C19H21NO2 (295.1572)


   

(3s,5r,7as,11ar)-5-butyl-3-(chloromethyl)-1h,2h,3h,5h,6h,7ah,10h,11h-pyrrolo[2,1-j]quinolin-7-one

(3s,5r,7as,11ar)-5-butyl-3-(chloromethyl)-1h,2h,3h,5h,6h,7ah,10h,11h-pyrrolo[2,1-j]quinolin-7-one

C17H26ClNO (295.1703)


   

7-methoxy-3-methyl-8-(3-methylbut-2-en-1-yl)-9h-carbazol-2-ol

7-methoxy-3-methyl-8-(3-methylbut-2-en-1-yl)-9h-carbazol-2-ol

C19H21NO2 (295.1572)


   

2-methyl-1-(3-methylpentyl)-9h-carbazole-3,4-dione

2-methyl-1-(3-methylpentyl)-9h-carbazole-3,4-dione

C19H21NO2 (295.1572)